<DOC>
	<DOCNO>NCT00922870</DOCNO>
	<brief_summary>Septic shock major cause mortality morbidity critically ill patient . Septic Shock associate overwhelming , systemic overflow pro inflammatory anti-inflammatory mediator , lead generalize endothelial damage , multiple organ failure , alter cellular immunological responsiveness . Although understand complex pathophysiological alteration occur septic shock increase greatly result recent clinical preclinical study , mortality associate disorder remain unacceptably high , range 30 % 50 % . To date , attempt improve survival innovative , predominantly anti-inflammatory therapeutic strategy disappoint . A standard hemofiltration rate 35 ml/kg/hour successfully use treat acute renal failure . However , dose alter plasma level inflammatory mediator , suggest ability clear mediator suboptimal . Higher dos hemofiltration ( 120 ml/kg per hour ) demonstrate improve cardiac function hemodynamics several animal model sepsis . High-volume hemofiltration ( HVHF ) thus conceive applied patient septic shock , show improvement hemodynamics decrease vasopressor requirement improve survival patient admit cardiac arrest . The main benefit describe high volume hemofiltration hemodynamic improvement ( e.g reduction catecholamine ' requirement ) . This improvement seem due removal badly define network middle molecular weight peptide . To remove efficiently middle molecular peptide , high filtration rate need . However , high filtration rate , also high clearance small molecule , include antibiotic , electrolyte , vitamin , trace element amino acid . The cascade hemofiltration system design efficient removal middle molecular weight peptide limit solute consumption . The goal study evaluation hemodynamic improvement use cascade hemofiltration patient treat septic shock .</brief_summary>
	<brief_title>Evaluation Hemodynamic Effects Cascade Hemofiltration Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Patient septic shock diagnose medical staff team . Patient mechanically ventilate treated high dos catecholamine adequate fluid administration ( ≥ 1.0 mg/h norepinephrine epinephrine ) ≥ 120 minute &lt; 24h . Age ( year ) &lt; 18 &gt; 85 . Weight &gt; 120 kg Thrombocytopenia 50 &lt; G/l Neutrophils &lt; 0.5 Giga/l Contra indication heparin anticoagulation . Patient require catecholamine ( epinephrine ≥ 1 mg/h norepinephrine ≥ 1 mg/h ) &gt; 24h . Patient admit ICU ≥ 7 day inclusion criterion . Comorbid condition expect survival &lt; 6 month Inclusion ( &lt; 28 day ) another study interfere goal current investigation . Pregnancy Immune compromise patient ( e.g . treated cancer , treat immunosuppressor steroid , AIDS ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>